Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

Objective: The diagnosis of infection in critically ill patients is challenging because traditional markers of infection are often misleading. For example, serum concentrations of calcitonin pre‐cursors are increased in patients with infections. However, their predictive accuracy for the diagnosis of sepsis in unselected patients in a medical intensive care unit (ICU) is unknown. Therefore, we compared the usefulness of serum concentrations of calcitonin precursors, C‐reactive protein, interleukin‐6, and lactate for the diagnosis of sepsis in consecutive patients suffering from a broad range of diseases with an anticipated stay of ≥ 24 hrs in a medical ICU. Design: Prospective cohort study. Setting: Medical intensive care unit in a university medical center. Patients: 101 consecutive critically ill patients. Intervention: None. Measurements and Main Results: Blood samples were collected at various time points during the course of the disease. Systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock were diagnosed according to standardized criteria, and patients were reclassified daily without prior knowledge of the serum concentrations of calcitonin precursors or interleukin‐6. At admission, 99% of the patients had systemic inflammatory response syndrome, 53% had sepsis, and 5% developed sepsis during their stay in the ICU. Calcitonin precursors, C‐reactive protein, interleukin‐6, and lactate levels increased with the severity of infection (p < .01, one‐way analysis of variance). In a receiver operating characteristic curve analysis, calcitonin precursors were found to be the most reliable laboratory variable for the diagnosis of sepsis as compared with C‐reactive protein, interleukin‐6, and lactate (p < .01, for each comparison). Calcitonin precursor concentrations of > 1 ng/mL had sensitivity of 89% and specificity of 94% for the diagnosis of sepsis. High serum concentrations of calcitonin precursors were associated with poor prognosis (p = .01). Conclusions: In a medical ICU, serum calcitonin precursor concentrations are more sensitive and are specific markers of sepsis as compared with serum C‐reactive protein, interleukin‐6, and lactate levels.

[1]  J. White,et al.  Serum calcitonin precursors in sepsis and systemic inflammation. , 1998, The Journal of clinical endocrinology and metabolism.

[2]  J. White,et al.  Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. , 1998, Critical care medicine.

[3]  R. Westendorp,et al.  Anti-inflammatory cytokine profile and mortality in febrile patients , 1998, The Lancet.

[4]  G. Steinbach,et al.  The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis , 1997, Gut.

[5]  J. Hughes,et al.  Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. , 1997, JAMA.

[6]  K. Becker,et al.  Effect of classic heatstroke on serum procalcitonin. , 1997, Critical care medicine.

[7]  D. Hober,et al.  Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. , 1997, The Journal of infection.

[8]  C Bohuon,et al.  Measurement of procalcitonin levels in children with bacterial or viral meningitis. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Chioléro,et al.  Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. , 1997, Critical care medicine.

[10]  Warren Hs.  Strategies for the treatment of sepsis. , 1997 .

[11]  M. Lamy,et al.  Sepsis and serum cytokine concentrations. , 1997, Critical care medicine.

[12]  J. Vincent,et al.  Dear SIRS, I'm sorry to say that I don't like you... , 1997, Critical care medicine.

[13]  F. Cohen,et al.  Microbial resistance to drug therapy: a review. , 1997, American journal of infection control.

[14]  K. Becker,et al.  Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[15]  M. Meisner,et al.  Procalcitonin - Influence of Temperature, Storage, Anticoagulation and Arterial or Venous Asservation of Blood Samples on Procalcitonin Concentrations , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[16]  K. Becker,et al.  Pneumonitis-associated hyperprocalcitoninemia. , 1996, The American journal of the medical sciences.

[17]  E. Deitch,et al.  Role of the Gut in Multiple Organ Failure: Bacterial Translocation and Permeability Changes , 1996, World Journal of Surgery.

[18]  D. Gendrel,et al.  Procalcitonin as a marker for the early diagnosis of neonatal infection. , 1996, The Journal of pediatrics.

[19]  François Gouin,et al.  Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults: A Multicenter Prospective Study in Intensive Care Units , 1995 .

[20]  F Doyon,et al.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. , 1995, JAMA.

[21]  J. Bion,et al.  A comparison of severity of illness scoring systems for intensive care unit patients: results of a multicenter, multinational study. The European/North American Severity Study Group. , 1995, Critical care medicine.

[22]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[23]  M. S. Lewis,et al.  Late pulmonary sequela following burns: persistence of hyperprocalcitonemia using a 1-57 amino acid N-terminal flanking peptide assay. , 1995, Respiratory medicine.

[24]  T. Davis,et al.  Serum procalcitonin concentrations in acute malaria. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  D. Wagner,et al.  Daily prognostic estimates for critically ill adults in intensive care units: Results from a prospective, multicenter, inception cohort analysis , 1994, Critical care medicine.

[26]  S. Lowry.  Sepsis and its complications: clinical definitions and therapeutic prospects. , 1994, Critical Care Medicine.

[27]  E. Moore,et al.  Effects of accidental trauma on cytokine and endotoxin production. , 1993, Critical care medicine.

[28]  R. Bone,et al.  Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.

[29]  K. Fassbender,et al.  Interleukin‐6 and acute‐phase protein concentrations in surgical intensive care unit patients: Diagnostic signs in nosocomial infection , 1993, Critical care medicine.

[30]  W. Shoemaker,et al.  Effects of accidental trauma on cytokine and endotoxin production , 1993, Critical care medicine.

[31]  M. Zweig,et al.  Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. , 1993, Clinical chemistry.

[32]  M. Assicot,et al.  High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.

[33]  J. Vincent,et al.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.

[34]  M. S. Lewis,et al.  Serum calcitonin may be a marker for inhalation injury in burns. , 1992, The Journal of burn care & rehabilitation.

[35]  K. Becker,et al.  Serum Procalcitonin as an Index of Inhalation Injury in Burns , 1992, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[36]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[37]  T. Calandra,et al.  High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. , 1991, The American journal of medicine.

[38]  M. Niederman,et al.  Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia. A common clinical sequence. , 1990, Clinics in chest medicine.

[39]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[40]  F. Ognibene,et al.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.

[41]  A. Groeneveld,et al.  Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. , 1990, Critical care medicine.

[42]  J. Van Snick.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[43]  M. Schlumberger,et al.  Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. , 1989, Cancer research.

[44]  P. Densen,et al.  Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo. , 1989, JAMA.

[45]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[46]  L. Manship,et al.  The influence of sepsis and multisystem and organ failure on mortality in the surgical intensive care unit. , 1984, The American surgeon.

[47]  C S Bryan,et al.  Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy. , 1983, Reviews of infectious diseases.

[48]  C. Hawker,et al.  Pathogenic mechanisms of the hypocalcemia of the staphylococcal toxic-shock syndrome. , 1983, The Journal of laboratory and clinical medicine.

[49]  E. Mallet,et al.  HYPERCALCITONINAEMIA IN FULMINANT MENINGOCOCCAEMIA IN CHILDREN , 1983, The Lancet.

[50]  P. Greenland,et al.  Selection and interpretation of diagnostic tests and procedures. Principles and applications. , 1981, Annals of internal medicine.

[51]  Jean-Guy Cyr,et al.  Principles and Practice of Infectious Diseases , 1980 .

[52]  D. Canale,et al.  Hypercalcitoninemia in acute pancreatitis. , 1975, The Journal of clinical endocrinology and metabolism.

[53]  R. Bryant,et al.  Factors affecting mortality of gram-negative rod bacteremia. , 1971, Archives of internal medicine.